{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:52:16Z","timestamp":1791460336889,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010790","name":"Erasmus Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010790","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.yrtph.2026.106212","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:11:25Z","timestamp":1785481885000},"page":"106212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effectiveness and limitations of environmental risk assessments to identify antibiotics of greatest concern in Australia"],"prefix":"10.1016","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4254-0340","authenticated-orcid":false,"given":"Isla","family":"Day","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6444-6827","authenticated-orcid":false,"given":"Martin","family":"Hensher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2026.106212_bib1","series-title":"Water Account, Australia, 2021-22 Financial Year","year":"2023"},{"issue":"4","key":"10.1016\/j.yrtph.2026.106212_bib4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1208\/s12248-016-9907-0","article-title":"Environmental risk assessment of pharmaceutical mixtures: demands, gaps, and possible bridges","volume":"18","author":"Backhaus","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.yrtph.2026.106212_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.envint.2015.10.015","article-title":"Concentrations of antibiotics predicted to select for resistant bacteria: proposed limits for environmental regulation","volume":"86","author":"Bengtsson-Palme","year":"2016","journal-title":"Environ. Int."},{"key":"10.1016\/j.yrtph.2026.106212_bib6","series-title":"Australia State of the Environment","article-title":"Coasts: population","author":"Clark","year":"2021"},{"key":"10.1016\/j.yrtph.2026.106212_bib7","series-title":"Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use","year":"2024"},{"key":"10.1016\/j.yrtph.2026.106212_bib8","series-title":"Technical Guidance Document on Risk Assessment. European Chemicals Bureau","author":"De","year":"2002"},{"key":"10.1016\/j.yrtph.2026.106212_bib9","unstructured":"Department of Health and Aged Care. (n.d.). PBS and RPBS Section 85 Date of Supply Data. Retrieved February 24, 2025, from https:\/\/www.pbs.gov.au\/info\/statistics\/dos-and-dop\/dos-and-dop."},{"issue":"10","key":"10.1016\/j.yrtph.2026.106212_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27103203","article-title":"Long-term calculation of predicted environmental concentrations to assess the risk of anticancer drugs in environmental waters","volume":"27","author":"Dominguez-Garc\u00eda","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.yrtph.2026.106212_bib12","series-title":"Guide to EPA Regulatory Expectations for Wastewater Management in Tasmania","year":"2020"},{"key":"10.1016\/j.yrtph.2026.106212_bib13","series-title":"Emerging Contaminants in Recycled Water (Text No. 2054). Environment Protection Authority Victoria","year":"2023"},{"key":"10.1016\/j.yrtph.2026.106212_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.envres.2015.02.015","article-title":"Predicting concentrations of cytostatic drugs in sewage effluents and surface waters of Catalonia (NE Spain)","volume":"138","author":"Franquet-Griell","year":"2015","journal-title":"Environ. Res."},{"key":"10.1016\/j.yrtph.2026.106212_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.envpol.2017.06.011","article-title":"Anticancer drugs: consumption trends in Spain, prediction of environmental concentrations and potential risks","volume":"229","author":"Franquet-Griell","year":"2017","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.yrtph.2026.106212_bib16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.scitotenv.2015.07.114","article-title":"Characterisation of microcontaminants in Darwin harbour, a tropical estuary of northern Australia undergoing rapid development","volume":"536","author":"French","year":"2015","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.yrtph.2026.106212_bib19","series-title":"Fate and Effects of Anticancer Drugs in the Environment","first-page":"27","article-title":"Predicted environmental concentrations: a useful tool to evaluate the presence of cytostatics in surface waters","author":"G\u00f3mez-Canela","year":"2020"},{"key":"10.1016\/j.yrtph.2026.106212_bib17","series-title":"Selection of Substances for the 4th Watch List Under the Water Framework Directive","author":"Gomez Cortez","year":"2022"},{"key":"10.1016\/j.yrtph.2026.106212_bib18","series-title":"Selection of Substances for the 5th Watch List Under the Water Framework Directive","author":"Gomez Cortez","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106212_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.105690","article-title":"Sale-based estimation of pharmaceutical concentrations and associated environmental risk in the Japanese wastewater system","volume":"139","author":"He","year":"2020","journal-title":"Environ. Int."},{"key":"10.1016\/j.yrtph.2026.106212_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2024.122643","article-title":"Predicting pharmaceutical concentrations and assessing risks in the aquatic environment using PERK: a case study of a catchment area in South-West England","volume":"268","author":"Jagadeesan","year":"2025","journal-title":"Water Res."},{"issue":"20","key":"10.1016\/j.yrtph.2026.106212_bib23","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1016\/S0043-1354(02)00227-0","article-title":"Aquatic environmental assessment of the top 25 English prescription pharmaceuticals","volume":"36","author":"Jones","year":"2002","journal-title":"Water Res."},{"key":"10.1016\/j.yrtph.2026.106212_bib24","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.scitotenv.2019.03.372","article-title":"Comparison of regulatory frameworks of environmental risk assessments for human pharmaceuticals in EU, USA, and Canada","volume":"671","author":"Lee","year":"2019","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.yrtph.2026.106212_bib25","series-title":"Environmental Risk Assessment Guidance Manual for Industrial Chemicals","author":"Lee-Steere","year":"2009"},{"issue":"13","key":"10.1016\/j.yrtph.2026.106212_bib26","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1021\/acs.est.5c00425","article-title":"Occurrence, removal, and risk assessment of antimicrobials and their transformation products in effluent from Australian wastewater treatment plants | Environmental Science & Technology","volume":"59","author":"Li","year":"2025","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.yrtph.2026.106212_bib27","series-title":"Review of the 1st Watch List Under the Water Framework Directive and Recommendations for the 2nd Watch List (EUR 29173 EN)","author":"Loos","year":"2018"},{"key":"10.1016\/j.yrtph.2026.106212_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.scitotenv.2015.04.051","article-title":"Environmental risk assessment of antibiotics including synergistic and antagonistic combination effects","volume":"524\u2013525","author":"Marx","year":"2015","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.yrtph.2026.106212_bib29","series-title":"Apply for a Licence to Market a Medicine in the UK","year":"2024"},{"issue":"10459","key":"10.1016\/j.yrtph.2026.106212_bib30","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.yrtph.2026.106212_bib31","series-title":"Assessment of Potential Risks of 11 Pharmaceuticals for the Environment","year":"2011"},{"issue":"11","key":"10.1016\/j.yrtph.2026.106212_bib33","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1007\/s11356-018-1343-5","article-title":"Predicted environmental concentration and fate of the top 10 Most dispensed Australian prescription pharmaceuticals","volume":"25","author":"Ong","year":"2018","journal-title":"Environ. Sci. Pollut. Control Ser."},{"key":"10.1016\/j.yrtph.2026.106212_bib34","series-title":"Antimicrobial Prescribing Practice in Australian Hospitals. Results of the 2022 Hospital National Antimicrobial Prescribing Survey","year":"2024"},{"key":"10.1016\/j.yrtph.2026.106212_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2024.124695","article-title":"Pharmaceuticals in biota: the impact of wastewater treatment plant effluents on fish in Australia","volume":"359","author":"Saaristo","year":"2024","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.yrtph.2026.106212_bib36","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.chemosphere.2017.06.102","article-title":"Anticancer drugs in Portuguese surface waters \u2013 estimation of concentrations and identification of potentially priority drugs","volume":"184","author":"Santos","year":"2017","journal-title":"Chemosphere"},{"issue":"5","key":"10.1016\/j.yrtph.2026.106212_bib37","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2134\/jeq2014.01.0012","article-title":"A National Survey of trace organic contaminants in Australian Rivers","volume":"43","author":"Scott","year":"2014","journal-title":"J. Environ. Qual."},{"issue":"9","key":"10.1016\/j.yrtph.2026.106212_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221568","article-title":"Translating antibiotic prescribing into antibiotic resistance in the environment: a hazard characterisation case study","volume":"14","author":"Singer","year":"2019","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.yrtph.2026.106212_bib39","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1248\/cpb.c21-00250","article-title":"Environmental risk assessment of active human pharmaceutical ingredients in urban Rivers in Japan","volume":"69","author":"Suzuki","year":"2021","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.yrtph.2026.106212_bib40","series-title":"Guidance for Industry\u2014Environmental Assessment of Human Drug and Biologics Applications","year":"1998"},{"issue":"8","key":"10.1016\/j.yrtph.2026.106212_bib42","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.scitotenv.2008.11.059","article-title":"The occurrence of antibiotics in an urban watershed: from wastewater to drinking water","volume":"407","author":"Watkinson","year":"2009","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.yrtph.2026.106212_bib43","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.chemosphere.2017.12.119","article-title":"Integrated toxic evaluation of sulfamethazine on zebrafish: including two lifespan stages (embryo-larval and adult) and three exposure periods (exposure, post-exposure and re-exposure)","volume":"195","author":"Yan","year":"2018","journal-title":"Chemosphere"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106212_bib44","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1080\/21655979.2021.1974657","article-title":"Antibiotics: an overview on the environmental occurrence, toxicity, degradation, and removal methods","volume":"12","author":"Yang","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.yrtph.2026.106212_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2021.131210","article-title":"Hepatotoxicity in carp (Cyprinus carpio) exposed to environmental levels of norfloxacin (NOR): some latest evidences from transcriptomics analysis, biochemical parameters and histopathological changes","volume":"283","author":"Zhang","year":"2021","journal-title":"Chemosphere"},{"issue":"6","key":"10.1016\/j.yrtph.2026.106212_bib46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/tox.22087","article-title":"Toxicity assessment of combined fluoroquinolone and tetracycline exposure in zebrafish (anio rerio)","volume":"31","author":"Zhang","year":"2016","journal-title":"Environ. Toxicol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026001856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026001856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:06:31Z","timestamp":1791457591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230026001856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":40,"alternative-id":["S0273230026001856"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106212","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and limitations of environmental risk assessments to identify antibiotics of greatest concern in Australia","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106212"}}